Indeed, following EZH2 excision, the expression profile during AML induction exhibited minimum overlap with that obtained from the maintenance phase of MLL-AF9 AML, with approximately 12% of genes (60 out of 496 genes) being common. The gene discussed is MLLT3; the disease is acute myeloid leukemia.